STOCK TITAN

Avantor Stock Price, News & Analysis

AVTR NYSE

Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.

Avantor (NYSE: AVTR) delivers essential materials and technologies powering breakthroughs in life sciences and advanced industries. This news hub provides investors and professionals with direct access to official announcements, including product innovations, financial results, and strategic partnerships shaping the future of bioprocessing and semiconductor manufacturing.

Track critical updates across Avantor's core operations: earnings disclosures detailing performance in pharmaceutical solutions, regulatory filings impacting global supply chains, and advancements in sustainable production methods like their viral vector processing systems. Discover how developments in brands like J.T. Baker and Macron Fine Chemicals influence research and manufacturing efficiency worldwide.

Our curated news collection serves as a decision-making tool for monitoring Avantor's role in enabling scientific progress across 180+ countries. Bookmark this page for real-time insights into leadership changes, facility expansions, and emerging applications in gene therapy support systems.

Rhea-AI Summary

Avantor (NYSE: AVTR) announced that its General Counsel, Justin Miller, has been honored as a 'Legend In Law' by The Burton Awards Program, recognizing his outstanding legal achievements. He is one of 13 honorees this year, acknowledged for his exceptional reputation and contributions to the legal profession. Miller's career highlights include a significant federal case win at age 26 and leading Avantor's initial public offering in May 2019. The awards celebrate leaders who tackle complex legal challenges on a national and global scale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
none
-
Rhea-AI Summary

Avantor, a global provider of mission-critical products and services, is set to release its third quarter 2020 financial results on October 28, 2020, after market close. A conference call will take place at 5:00 p.m. EDT the same day to discuss the results. Investors can join the call by dialing (866) 211-4132 domestically or (647) 689-6615 internationally, using access code 3557106. The earnings press release and related slides will be available on their website. A replay will be accessible until November 12, 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
conferences earnings
-
Rhea-AI Summary

Avantor has appointed Frederic Vanderhaegen as Executive Vice President for the Americas and Europe, effective immediately. He expands his role to include the Americas, enhancing the company's focus on customer research and development. This strategic move aims to improve customer service and innovation in the company’s offerings. Vanderhaegen, who joined Avantor in 2018, brings extensive leadership experience in the life sciences sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.11%
Tags
management
Rhea-AI Summary

Avantor, a global leader in mission-critical products and services, will participate in the Morgan Stanley Virtual Healthcare Conference on September 16, 2020. CEO Michael Stubblefield is scheduled to present at 8:45 a.m. ET. Investors can access a live webcast through Avantor's investor relations page, which will remain available for replay until September 30, 2020. Avantor serves over 225,000 customers across various sectors, including biopharma and healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Avantor, a leading global provider of critical products and services, will participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 10, 2020. President and CEO Michael Stubblefield will represent the company at approximately 10:00 a.m. Eastern Time. A live webcast will be available through Avantor's investor relations section and can be replayed until September 24, 2020. Avantor serves over 225,000 customer locations globally, supporting the biopharma, healthcare, education, and technology sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.64%
Tags
conferences
-
Rhea-AI Summary

Avantor, Inc. (NYSE: AVTR) announced the pricing of an upsized secondary offering by certain stockholders, including New Mountain Capital. A total of 55,555,555 shares of common stock will be sold for gross proceeds of approximately $1.1 billion. This is an increase from the originally proposed 38,500,000 shares. The offering will close on August 21, 2020, pending customary conditions. The underwriters have an option to purchase an additional 8,333,333 shares. The company itself is not selling any shares and will not receive any proceeds from this offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
none
Rhea-AI Summary

Avantor, Inc. (NYSE: AVTR) announced an underwritten secondary offering of 38,500,000 shares of common stock by certain stockholders, including an affiliate of New Mountain Capital. The underwriters, Goldman Sachs & Co. LLC and J.P. Morgan, may acquire an additional 5,775,000 shares. The proceeds will go entirely to the selling stockholders, as no shares are being sold by the company itself. A registration statement with the SEC has been filed and is effective. The offering will be conducted via a prospectus supplement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
none
-
Rhea-AI Summary

Avantor (NYSE: AVTR) announced an upgrade of its long-term issuer default rating (IDR) to 'BB-' with a Positive Outlook by S&P Global Ratings as of August 10, 2020. This upgrade reflects Avantor's robust business model and cash generation capacity, underscoring the company's strong market position in life sciences and advanced technologies. The firm's Executive Vice President and CFO, Thomas Szlosek, expressed confidence in the ongoing deleveraging of the balance sheet. The upgrade represents a significant step in enhancing Avantor's credit standing in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.48%
Tags
none
-
Rhea-AI Summary

Avantor, a global provider of critical products in life sciences, reported Q2 2020 results showing net sales of $1.48 billion, a 3.5% decline year-over-year. Adjusted EBITDA grew to $273 million, marking a 2% increase. Net income rose to $60.2 million, a turnaround from a loss in the prior year. The company refinanced $2 billion in unsecured notes, reducing annual interest expenses by over $90 million. Despite challenges from COVID-19, Avantor reports resilience with positive cash flow generation of $316.2 million in H1 2020, a 641% increase from the prior year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.53%
Tags
Rhea-AI Summary

Avantor, Inc. (NYSE: AVTR) has declared a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock, reflecting a rate of 1.560%. The dividend will be payable on August 15, 2020, to holders of record as of August 1, 2020. This announcement underscores Avantor's commitment to return value to its shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
dividends

FAQ

What is the current stock price of Avantor (AVTR)?

The current stock price of Avantor (AVTR) is $11.43 as of December 26, 2025.

What is the market cap of Avantor (AVTR)?

The market cap of Avantor (AVTR) is approximately 7.7B.
Avantor

NYSE:AVTR

AVTR Rankings

AVTR Stock Data

7.69B
657.57M
1.37%
106.68%
4.4%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
RADNOR